MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Pareek, Siddhika ^a   Roy, Saugata ^a   Kumari, Bharti ^a   Jain, Pratistha ^a   Banerjee, Arup ^a   Vrati, Sudhanshu ^a  

^a Translational Health Science and Technology Institute   (India)

Author keywords

CD45; JEV; Microglia activation; NeurimmiRs

Indexed keywords

CD45 ANTIGEN; COMPLEMENT FACTOR H; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; MICRORNA 146A; MICRORNA 155; STAT1 PROTEIN; VIRUS RNA; COMPLEMENT FACTOR H, HUMAN; CYTOKINE; ENZYME INHIBITOR; MESSENGER RNA; MICRORNA; MIRN146 MICRORNA, HUMAN; MIRN155 MICRORNA, HUMAN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MICROGLIA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; VIRUS CULTURE; VIRUS REPLICATION; WESTERN BLOTTING; ANALYSIS OF VARIANCE; DRUG EFFECTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSFORMED CELL LINE; VIROLOGY;

ANALYSIS OF VARIANCE; CELL LINE, TRANSFORMED; COMPLEMENT FACTOR H; CYTOKINES; ENCEPHALITIS VIRUS, JAPANESE; ENZYME INHIBITORS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, VIRAL; HUMANS; IMMUNITY, INNATE; MICROGLIA; MICRORNAS; NF-KAPPA B; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; VIRUS REPLICATION;

EID: 84902320438     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-97     Document Type: Article

References (48)

1. Thongtan T, Cheepsunthorn P, Chaiworakul V, Rattanarungsan C, Wikan N, Smith DR. Highly permissive infection of microglial cells by Japanese encephalitis virus: a possible role as a viral reservoir. Microbes Infect 2010, 12:37-45. 10.1016/j.micinf.2009.09.013, 19786116.
2. Chen CJ, Ou YC, Lin SY, Raung SL, Liao SL, Lai CY, Chen SY, Chen JH. Glial activation involvement in neuronal death by Japanese encephalitis virus infection. J Gen Virol 2010, 91:1028-1037. 10.1099/vir.0.013565-0, 20007359.
3. Das S, Dutta K, Kumawat KL, Ghoshal A, Adhya D, Basu A. Abrogated inflammatory response promotes neurogenesis in a murine model of Japanese encephalitis. PLoS One 2011, 6:e17225. 10.1371/journal.pone.0017225, 3048396, 21390230.
4. Kobayashi K, Imagama S, Ohgomori T, Hirano K, Uchimura K, Sakamoto K, Hirakawa A, Takeuchi H, Suzumura A, Ishiguro N, Kadomatsu K. Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis 2013, 4:e525. 10.1038/cddis.2013.54, 3613832, 23470532.
5. Mishra MK, Basu A. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J Neurochem 2008, 105:1582-1595. 10.1111/j.1471-4159.2008.05238.x, 18208541.
6. Ponomarev ED, Veremeyko T, Weiner HL. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 2013, 61:91-103. 10.1002/glia.22363, 3434289, 22653784.
7. Skalsky RL, Cullen BR. Viruses, microRNAs, and host interactions. Annu Rev Microbiol 2010, 64:123-141. 10.1146/annurev.micro.112408.134243, 3621958, 20477536.
8. Soreq H, Wolf Y. NeurimmiRs: microRNAs in the neuroimmune interface. Trends Mol Med 2011, 17:548-555. 10.1016/j.molmed.2011.06.009, 21813326.
9. Wanet A, Tacheny A, Arnould T, Renard P. miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res 2012, 40:4742-4753. 10.1093/nar/gks151, 3367188, 22362752.
10. Lindsay MA. microRNAs and the immune response. Trends Immunol 2011, 29:343-351.
11. Elton TS, Selemon H, Elton SM, Parinandi NL. Regulation of the MIR155 host gene in physiological and pathological processes. Gene 2013, 532:1-12. 10.1016/j.gene.2012.12.009, 23246696.
12. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010, 10:111-122. 10.1038/nri2708, 20098459.
13. Cardoso AL, Guedes JR, Pereira de Almeida L, Pedroso de Lima MC. miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology 2012, 135:73-88. 10.1111/j.1365-2567.2011.03514.x, 3246654, 22043967.
14. Saba R, Gushue S, Huzarewich RLCH, Manguiat K, Medina S, Robertson C, Booth SA. MicroRNA 146a (miR-146a) is overexpressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS One 2012, 7:e30832. 10.1371/journal.pone.0030832, 3281888, 22363497.
15. Hou J, Wang P, Lin L, Liu X, Ma F, An H, Wang Z, Cao X. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009, 183:2150-2158. 10.4049/jimmunol.0900707, 19596990.
16. Wang P, Hou J, Lin L, Wang C, Liu X, Li D, Ma F, Wang Z, Cao X. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol 2010, 185:6226-6233. 10.4049/jimmunol.1000491, 20937844.
17. Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN. Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD). Int J Biochem Mol Biol 2012, 3:105-116. 3325769, 22509485.
18. Lukiw WJ, Alexandrov PN. Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol Neurobiol 2012, 46:11-19. 10.1007/s12035-012-8234-4, 3703615, 22302353.
19. Li YY, Alexandrov PN, Pogue AI, Zhao Y, Bhattacharjee S, Lukiw WJ. miRNA-155 upregulation and complement factor H deficits in Down's Syndrome. Nuroreport 2012, 23:168-173.
20. Wu S, He L, Li Y, Wang T, Feng L, Jiang L, Zhang P, Huang X. miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6. J Infect 2013, 67:329-341. 10.1016/j.jinf.2013.05.003, 23685241.
21. Swaminathan G, Rossi F, Sierra LJ, Gupta A, Navas-Martín S, Martín-García J. A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages. PLoS Pathog 2012, 8:e1002937. 10.1371/journal.ppat.1002937, 3447756, 23028330.
22. Vrati S, Agarwal V, Malik P, Wani SA, Saini M. Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth. J Gen Virol 1999, 80:1665-1671.
23. Kalia M, Khasa R, Sharma M, Nain M, Vrati S. Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism. J Virol 2013, 87:148-157. 10.1128/JVI.01399-12, 3536362, 23055570.
24. El-Ekiaby N, Hamdi N, Negm M, Ahmed R, Zekri AR, Esmat G, Abdelaziz AI. Repressed induction of interferon-related microRNAs miR-146a and miR-155 in peripheral blood mononuclear cells infected with HCV genotype 4. FEBS Open Bio 2012, 2:179-186. 3642156, 23650597.
25. Li P, Wong JJ, Sum C, Sin WX, Ng KQ, Koh MB, Chin KC. IRF8 and IRF3 cooperatively regulate rapid interferon-β induction in human blood monocytes. Blood 2011, 117:2847-2854. 10.1182/blood-2010-07-294272, 21228327.
26. Tsujimura H, Tamura T, Kong HJ, Nishiyama A, Ishii KJ, Klinman DM, Ozato K. Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J Immunol 2004, 172:6820-6827. 10.4049/jimmunol.172.11.6820, 15153500.
27. Larena M, Regner M, Lobigs M. The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists. Is critical for recovery in a mouse model of Japanese encephalitis. PLoS One 2012, 7:e44834. 10.1371/journal.pone.0044834, 3448613, 23028638.
28. Boldin MP, Baltimore D. MicroRNAs, new effectors and regulators of NF-κB. Immunol Rev 2012, 246:205-220. 10.1111/j.1600-065X.2011.01089.x, 22435557.
29. Town T, Nikolic V, Tan J. The microglial " activation" continuum: from innate to adaptive responses. J Neuroinflammation 2005, 2:24. 10.1186/1742-2094-2-24, 1298325, 16259628.
30. Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, Welstead G, Griffiths E, Krawczyk C, Richardson CD, Aitken K, Iscove N, Koretzky G, Johnson P, Liu P, Rothstein DM, Penninger JM. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signaling. Nature 2001, 409:349-354. 10.1038/35053086, 11201744.
31. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003, 21:107-137. 10.1146/annurev.immunol.21.120601.140946, 12414720.
32. Cremer TJ, Fatehchand K, Shah P, Gillette D, Patel H, Marsh RL, Besecker BY, Rajaram MV, Cormet-Boyaka E, Kanneganti TD, Schlesinger LS, Butchar JP, Tridandapani S. MiR-155 induction by microbes/microbial ligands requires NF-κB-dependent de novo protein synthesis. Front Cell Infect Microbiol 2012, 2:73. 3417573, 22919664.
33. Berghout J, Langlais D, Radovanovic I, Tam M, MacMicking JD, Stevenson MM, Gros P. Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria. PLoS Pathog 2013, 9:e1003491. 10.1371/journal.ppat.1003491, 3708918, 23853600.
34. Horiuchi M, Wakayama K, Itoh A, Kawai K, Pleasure D, Ozato K, Itoh T. Interferon regulatory factor 8/interferon consensus sequence binding protein is a critical transcription factor for the physiological phenotype of microglia. J Neuroinflammation 2012, 9:227. 10.1186/1742-2094-9-227, 3546867, 23020843.
35. Fragale A, Stellacci E, Ilari R, Remoli AL, Lanciotti A, Perrotti E, Shytaj I, Orsatti R, Lawrence HR, Lawrence NJ, Wu J, Rehli M, Ozato K, Battistini A. Critical role of IRF-8 in negative regulation of TLR3 expression by Src homology 2 domain-containing protein tyrosine phosphatase-2 activity in human myeloid dendritic cells. J Immunol 2011, 186:1951-1962. 10.4049/jimmunol.1000918, 21220691.
36. Salemi J, Obregon DF, Cobb A, Reed S, Sadic E, Jin J, Fernandez F, Tan J, Giunta B. Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD). Mol Neurodegener 2011, 6:3. 10.1186/1750-1326-6-3, 3030526, 21223591.
37. Masuda T, Tsuda M, Yoshinaga R, Tozaki-Saitoh H, Ozato K, Tamura T, Inoue K. IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep 2012, 1:334-340. 10.1016/j.celrep.2012.02.014, 22832225.
38. Baur A, Garber S, Peterlin BM. Effects of CD45 on NF-kappa B. Implications for replication of HIV-1. J Immunol 1994, 152:976-983.
39. Chung KM, Liszewski MK, Nybakken G, Davis AE, Townsend RR, Fremont DH, Atkinson JP, Diamond MS. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci USA 2006, 103:19111-19116. 10.1073/pnas.0605668103, 1664712, 17132743.
40. Thounaojam MC, Kundu K, Kaushik DK, Swaroop S, Mahadevan A, Shankar SK, Basu A. MicroRNA-155 regulates Japanese encephalitis virus induced inflammatory response by targeting src homology 2-containing inositol phosphatase-1 (SHIP1). J Virol 2014, 88:4798-4810. 10.1128/JVI.02979-13, 24522920.
41. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA 2009, 106:2735-2740. 10.1073/pnas.0811073106, 2650335, 19193853.
42. Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, Wang F, Wu Y, Tong WD, Guo H, Mao XH, Zou QM. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 2009, 200:916-925. 10.1086/605443, 19650740.
43. Xu C, Ren G, Cao G, Chen Q, Shou P, Zheng C, Du L, Han X, Jiang M, Yang Q, Lin L, Wang G, Yu P, Zhang X, Cao W, Brewer G, Wang Y, Shi Y. miR-155 regulates immune modulatory properties of mesenchymal stem cells by targeting TAK1-binding protein 2. J Biol Chem 2013, 288:11074-11079. 10.1074/jbc.M112.414862, 3630877, 23449975.
44. Sullivan RP, Fogel LA, Leong JW, Schneider SE, Wong R, Romee R, Thai TH, Sexl V, Matkovich SJ, Dorn GW, French AR, Fehniger TA. MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathways. J Immunol 2013, 12:5904-5913.
45. Zhou H, Huang X, Cui H, Luo X, Tang Y, Chen S, Wu L, Shen N. miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 2010, 116:5885-5894. 10.1182/blood-2010-04-280156, 20852130.
46. Lu F, Weidmer A, Liu CG, Volinia S, Croce CM, Lieberman PM. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 2008, 82:10436-10443. 10.1128/JVI.00752-08, 2573162, 18753206.
47. Tang B, Xiao B, Liu Z, Li N, Zhu ED, Li BS, Xie QH, Zhuang Y, Zou QM, Mao XH. Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. FEBS Lett 2010, 584:1481-1486. 10.1016/j.febslet.2010.02.063, 20219467.
48. Ma X, Becker Buscaglia LE, Barker JR, Li Y. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 2011, 3:159-166. 10.1093/jmcb/mjr007, 3104013, 21502305.